In contradiction to recent studies that linked Ras signalling and the Hippo pathway in a subset of tumours and cell lines33,34, the expression of KRAS G12V alone or in combination with loss of p53 and p16 was not sufficient to activate Yap in C2C12 myoblasts or in U57810 RMS cells. The gene discussed is KRAS; the disease is neoplasm.